About Cochlear

Cochlear Limited engages in the research, development, manufacture, and marketing of implantable hearing solutions. Implant System The cochlear implant system restores the ability to perceive and understand sound. It is the solution for people with severe to profound sensorineural hearing loss in both ears. Cochlear Hybrid This hearing solution is for people who have useful low frequency residual hearing but require electrical stimulation for the higher frequencies. The external Hybrid speech processor is a fully integrated speech processor that combines both electrical and acoustic stimulation capabilities. Cochlear Baha The Baha system is the hearing solution for people with significant conductive hearing loss, mixed hearing loss or single sided deafness (SSD). The Baha Intenso, introduced in 2007, is a head-worn digital Baha device. It delivers clearer sound quality in all types of listening environments. The Baha system combines a small titanium implant, a connecting abutment, and a detachable sound processor. The titanium implant osseointegrates with bone (titanium and bone merge) allowing sound to be conducted directly to the cochlea. Sounds can be heard as the damaged portions of the ear — outer and middle — are bypassed. DACS The direct acoustic cochlear stimulator (DACS) is a type of implantable hearing device, which would expand hearing solutions. The DACS system is being designed to provide a solution for people with severe to profound mixed hearing impairment. DACS provides mechanical (acoustic) stimulation directly to the cochlea. Significant Events On October 14, 2009, Cochlear Ltd. and NXP Semiconductors announced that they have signed an agreement for the design and manufacturing of IC devices for Cochlear's future generation Implantable Hearing devices. The agreement includes the definition, development and supply of ultra low power speech processor and wireless communication ICs to be used in Cochlear's next generation products.